Drug profile · INN
ofatumumab
KESIMPTA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ofatumumab (KESIMPTA) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ofatumumab
Brand KESIMPTA
Route INJECTION
Formulation INJECTABLE
ATC code L04AA52
Originator Novartis Pharmaceuticals
Frequently asked questions
What is ofatumumab?
ofatumumab (KESIMPTA) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ofatumumab?
KESIMPTA is a marketed brand name for ofatumumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ofatumumab?
ofatumumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.